Lumigan vs Caverject: side-by-side comparison
Lumigan (Ophtalmologie et traitements oculaires) and Caverject (Dysfonction érectile) belong to different therapeutic classes and are rarely interchangeable. This page compares the medications' purposes, mechanisms and the situations where each is used.
| Property | Lumigan | Caverject |
|---|---|---|
| Active ingredient | Bimatoprost | Alprostadil |
| Manufacturer | AbbVie / Allergan | Pfizer |
| Class | Ophtalmologie et traitements oculaires | Dysfonction érectile |
| Strengths | 0.01%, 0.03% | 10mcg, 20mcg, 40mcg |
| Forms | ophthalmic solution | injection |
What's the same
Lumigan and Caverject are used in very different patients, and the points in common are limited. The main shared element is that both meet regulatory standards for efficacy and safety and benefit from pharmacist oversight.
Key differences
Lumigan belongs to Ophtalmologie et traitements oculaires while Caverject belongs to Dysfonction érectile. Indications, mechanisms and target populations differ. The comparison is most useful when a clinician has mentioned both medications and the patient wants to understand where each fits.
Mechanism and action
Lumigan: Le bimatoprost est un analogue des prostamides qui augmente l'écoulement de l'humeur aqueuse par le trabéculum et par la voie uvéosclérale, abaissant la pression intraoculaire. Caverject: L'alprostadil se lie aux récepteurs des prostaglandines E situés sur le muscle lisse du corps caverneux et déclenche, par la voie de l'AMP cyclique, un relâchement musculaire indépendant de la voie du monoxyde d'azote qu…
When Lumigan is preferred
Lumigan est autorisé chez l'adulte dans la réduction de la pression intraoculaire élevée en cas de glaucome chronique à angle ouvert ou d'hypertonie oculaire.
When Caverject is preferred
Caverject est autorisé dans la dysfonction érectile d'origine vasculaire, neurogène, psychogène ou mixte chez l'homme adulte.
Questions fréquentes
Is Lumigan or Caverject better? ▾
Lumigan and Caverject are not interchangeable — they treat different conditions. Asking which is "better" is meaningful only when a clinician has weighed both for the same specific clinical scenario.
Can I switch from Lumigan to Caverject? ▾
Switching between Lumigan and Caverject is rarely an appropriate decision since they belong to different classes and treat different conditions. The real question is usually whether the diagnosis calls for one medication or the other — which the prescriber resolves.
Do Lumigan and Caverject have the same side effects? ▾
No — they belong to different classes and have distinct side-effect profiles. Each medication has its own prescribing information.
More Lumigan comparisons
Les informations publiées sur ce site sont fournies à titre documentaire et pédagogique. Elles ne remplacent pas l'avis d'un professionnel de santé qualifié.